Orthopediatrics Executive Compensation (FY25)

Name: Orthopediatrics (KIDS) executive compensation
Creator: Velarion
License: https://intel.velarion.ai/terms

KIDS · Executive and director compensation, fiscal 2025 only

The paid brief on Orthopediatrics

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

$1,500 for the Executive Compensation Report. Both reports for $2,400.

Get the executive brief Get the board briefNo account needed.

Data as of September 7, 2026Latest filing (DEF 14A): April 20, 2026

1 filing cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Orthopediatrics brief$1,500Get the executive brief

104 figures on this page, cited to the filing that reported them. See the citations

Chief executive, fiscal 2025

◇

David Bailey

Chief executive pay ratio

◇

To the median employee

Frequently asked questions

Answers drawn from the data on this page.

Who is Orthopediatrics' chief executive and what were they paid?

David Bailey was paid $3,331,481 in total compensation as President and Chief Executive Officer for fiscal 2025.

What is Orthopediatrics' chief executive pay ratio?

The company reported a chief executive pay ratio of 32:1 for fiscal 2025.

Executive compensation

Every element reported for each named executive officer, by fiscal year.

Fiscal 2025

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
David Bailey President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Fred Hite Chief Operating Officer and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Joseph Hauser President of Trauma, Deformity and OPSB	◇	—	◇	—	◇	—	◇	◇
Gregory Odle President of Scoliosis	◇	—	◇	—	◇	—	◇	◇
Daniel Gerritzen Executive Vice President (Legal), General Counsel, and Secretary	◇	—	◇	—	◇	—	◇	◇

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.

Fiscal 2025

Officer	Award	Grant date	Threshold units	Target units	Units granted	Maximum units	Exercise price	Grant date fair value
Daniel J. Gerritzen	PSU	◇	—	◇	—	◇	—	◇
David R. Bailey	PSU	◇	—	◇	—	◇	—	◇
Fred L. Hite	PSU	◇	—	◇	—	◇	—	◇
Gregory A. Odle	PSU	◇	—	◇	—	◇	—	◇
Joseph W. Hauser	PSU	◇	—	◇	—	◇	—	◇

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.

As disclosed at fiscal 2025 year end

Officer	Award	Unvested units	Market value of unvested units	Exercise price	Expires
David Bailey	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Joseph Hauser	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Gregory Odle	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Fred Hite	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Daniel Gerritzen	RSU	◇	◇	—	—
	RSU	◇	◇	—	—

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.

Fiscal 2025

Director	Fees earned in cash	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Bryan W. Hughes	◇	◇	—	—	—	—	◇
Marie C. Infante	◇	◇	—	—	—	—	◇
Mark C. Throdahl Board chair	◇	◇	—	—	—	—	◇
Terry Schlotterback	◇	◇	—	—	—	—	◇
Jimmy D. McDonald	◇	◇	—	—	—	—	◇
Samuel D. Riccitelli Lead independent director	◇	◇	—	—	—	—	◇
David R. Pelizzon	◇	◇	—	—	—	—	◇
George S. M. Dyer	◇	◇	—	—	—	—	◇
Harald Ruf	◇	◇	—	—	—	—	◇
Kelly Fischer	—	◇	—	—	—	—	◇

David R. Bailey and Fred L. Hite served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.

Board cash retainer	◇
Board equity retainer	◇
Total board retainer	◇
Board chair premium	◇
Compensation committee chair	◇
Nominating and governance chair	◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Chief executive pay ratio

As calculated and reported by the company.

Ratio

◇

Chief executive total compensation

◇

What this page does not include

Everything above is a fact Orthopediatrics disclosed, and it is free. Everything below is our analysis of those facts, and it is not.

Written compensation analysis

A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.

Executive Compensation Report — $1,500

Board and governance analysis

Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.

Board Governance Report — $1,200

Realizable pay

What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.

Velarion Intelligence

Adviser switching and vote outcomes

Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.

Inquire about access

Multiple companies at once

Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.

Velarion Intelligence

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.

104 figures on this page, cited to the filing that reported them.

104 cited to the filing

Documents cited

DEF 14A, filed April 20, 2026
0001425450-26-000027
Director Compensation · Executive Officer and Director Compensation · Grants of Plan-Based Awards · Outstanding Equity Awards at Fiscal Year End · and 1 more section

Cite this data

This page is free to cite. Attribution we ask for:

Velarion, “Orthopediatrics executive compensation, FY2025.” https://intel.velarion.ai/comp/KIDS (accessed 2026).

Short form: data: Velarion

The paid brief for Orthopediatrics

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

$1,500 for the Executive Compensation Report. Both reports for $2,400.

Get the executive brief Get the board briefNo account needed.

1 filing cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Embed this data

A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.

The headline figures, each with its citation.

<iframe src="https://intel.velarion.ai/comp/KIDS/embed" width="560" height="480" style="border:1px solid #d8dee8;border-radius:10px" loading="lazy" title="Orthopediatrics executive compensation, from Velarion"></iframe>

Connect an AI assistant

Ask your own assistant about Orthopediatrics and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

{
  "mcpServers": {
    "velarion": {
      "type": "http",
      "url": "https://api.velarion.ai/mcp"
    }
  }
}

Setup guide and the full list of questions it answers

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data

APA

Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854

BibTeX

@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}

More on Orthopediatrics

Frequently asked questions

Executive compensation

Equity awards granted

Outstanding awards

Director compensation

Director fee schedule

Disclosed peer group

Chief executive pay ratio

What this page does not include

Citations

Documents cited

The paid brief for Orthopediatrics